The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart disease.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | STAT+: Novo Nordisk inflammation-targeting drug misses mark in heart disease study | 0 | 7.41 | 31-07-2026 |
| 2 | STAT+: AstraZeneca, Ionis report major trial failure with heart disease drug | -2 | 7 | 09-07-2026 |
| 3 | Herz-Medikament: Novo Nordisk mit Entwicklungsfehlschlag – Aktienkurs sackt ab | 0 | 12.84 | 31-07-2026 |
| 4 | What is pulmonary hypertension and why would a new GLP-1 help? | 0 | 5 | 26-06-2026 |
| 5 | Kidney cancer drug could slash the risk of repeated heart attacks in a similar way to statins, study suggests | 0 | 8.9 | 01-09-2024 |
| 6 | National Institutes of Health testing controversial Covid drug as new cancer treatment | 0 | 8.01 | 11-02-2026 |
| 7 | Акции западного фармгиганта обвалились после неудачных испытаний лекарства | -3 | 6 | 09-07-2026 |
| 8 | Researchers identify immune trigger behind myocarditis after COVID-19 vaccination | 0 | 9.44 | 15-12-2025 |
| 9 | This 10-cent heart drug cuts hospitalizations by 25% | 0 | 16.47 | 16-08-2026 |
| 10 | Anabolic steroid use can increase heart disease risk, study finds | 0 | 5 | 13-02-2024 |